COLUMBUS, OH
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)OHIO CANCER RESEARCH ASSOCIATES, founded in 1982, is a small nonprofit in the Medical Research sector that reported $580K in total revenue in fiscal year 2024. Revenue decreased 20% compared to the prior year. Expenses of $645K exceeded revenue, resulting in a 11% operating deficit.
OHIO CANCER RESEARCH IS DEDICATED TO THE CURE AND PREVENTION OF CANCER AND THE REDUCTION OF ITS DEBILITATING EFFECTS BY PROVIDING CRITICAL SEED MONEY FOR GROUNDBREAKING RESEARCH IDEAS.
PROVIDING CRITICAL SEED GRANTS TO SUPPORT FOUNDATIONAL, NEW IDEAS BY CANCER RESEARCHERS THAT ULTIMATELY SAVE, EXTEND AND IMPROVE LIVES. THESE GRANTS, SELECTED ONLY ON MERIT AS DETERMINED BY AN...
PROVIDING CRITICAL SEED GRANTS TO SUPPORT FOUNDATIONAL, NEW IDEAS BY CANCER RESEARCHERS THAT ULTIMATELY SAVE, EXTEND AND IMPROVE LIVES. THESE GRANTS, SELECTED ONLY ON MERIT AS DETERMINED BY AN INDEPENDENT SCIENTIFIC REVIEW COMMITTEE, ALLOW INVESTIGATORS TO OBTAIN DATA NECESSARY TO ACQUIRE MUCH LARGER FUNDING FROM SOURCES SUCH AS THE NATIONAL INSTITUTES OF HEALTH. 95% OF OUR GRANT RECIPIENTS RECEIVE ADDITIONAL FUNDING. 8 MILLION OF GRANTS AWARDED BY OHIO CANCER RESEARCH(OCR)HAS NOW GENERATED MORE THAN 1 BILLION IN ADDITIONAL FUNDING TO CANCER RESEARCHERS. ON AVERAGE, EACH DOLLAR OCR AWARDS TO A GROUNDBREAKING IDEA RESULTS IN OVER 130 OF ADDITIONAL FUNDING FROM OTHER SOURCES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $580,314 | $725,256 | -0.2% |
| Expenses | $644,855 | $589,826 | +0.1% |
| Net Income | $-64,541 | $135,430 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GRANT VARIAN MD | BOARD CHAIRM | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| DEBORAH PARRIS PHD | PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| SUSAN COLE PHD | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| JOHN KESSLER | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| LYNN ELLIOTT | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| WILLIAM R BOGGESS | EXECUTIVE DI | 40.00 |
Director
|
$123,188 | $45,079 | $168,267 |
| JUSTIN LATHIA | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| MATTHEW SUMMERS | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $580,314 | $644,855 | $582,004 | $-64,541 |
| 2023 | $725,256 | $589,826 | $610,340 | $135,430 |
| 2022 | $601,399 | $481,857 | $366,928 | $119,542 |
| 2021 | $836,728 | $522,350 | $302,143 | $314,378 |
| 2020 | $493,852 | $514,703 | $167,988 | $-20,851 |
| 2019 | $759,673 | $557,183 | $127,659 | $202,490 |
| 2018 | $856,947 | $756,113 | $56,083 | $100,834 |
Compare OHIO CANCER RESEARCH ASSOCIATES with other nonprofits in Ohio and across the country.